5 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Withdrawal of Heart Failure Treatment Patients With Non-ischemic Cardiomyopathy Who Have Been Super-responders to Cardiac Resynchronization Therapy.Cardiac Resynchronisation Therapy (CRT); Non-ischemic CardiomyopathyRecruitingPhase 42026-10-01NCT07851779
A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line TherapyAdnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, carcinoma, clear cell adenocarcinoma, endocrine system disorder, epithelial neoplasm, fallopian tube cancer, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, primary peritoneal carcinomaRecruitingPhase 22026-07-27NCT05460000
Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancershuman papillomavirus-related penile squamous cell carcinoma, neoplasmActive, not recruitingPhase 1 / Phase 22026-02-05NCT03260023
PEARL Study: PotEntial of Asciminib in the eaRly Treatment of CMLChronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone marrow disorder, hematologic disorder, leukemia, myeloid leukemia, neoplasmRecruitingPhase 22025-07-08NCT06409936
Left Septal or Deep Septal Pacing to Prevent Pacing-induced CardiomyopathyMobitz type II atrioventricular block, third-degree atrioventricular blockRecruitingNot applicable2024-07-15NCT06474819